New York attorney-general Letitia James has announced the resolution of the lawsuit against the Sackler family and their firm, Purdue Pharma. As per the press statement of James, the settlement will permanently stop the manufacture of opioids by the family and Purdue. Furthermore, the payment fro...
Purdue Pharma 和Sacklers達成74億美元鴉片類藥物和解協議 2025年1月,普渡製藥公司與其所有者薩克勒家族就美國數千起涉及奧施康定(OxyContin)的訴訟達成了一項74 億美元的和解協議。此協議旨在解決因該止痛藥引發的廣泛鴉片類藥物成癮危機,這場危機在美國已經導致超過70 萬人死亡。 ▌和解協議的內容 根據新的和解協議,...
A narrowly divided Supreme Court in a 5-4decisionstruck down a hard-fought bankruptcy plan for OxyContin manufacturer Purdue Pharma that would have awarded $6 billion to state and local governments to fight opioid addiction and payouts to more than 100,000 ...
Though the Sackler family, which owned Purdue, did not enter bankruptcy, they negotiated a settlement with claimants. The Sacklers agreed to contribute more than $4 billion across a decade — an amount that ultimately rose to $6 billion — toward efforts to fight the opioid crisis. The settl...
Bankruptcy Judge OKs Federal Settlement With Purdue Pharma More The Associated Press FILE - In this Tuesday, May 8, 2007, file photo, a Purdue Pharma logo is affixed to part of a Purdue building in Stamford, Conn. Proposed settlements between the federal government and OxyContin maker Pur...
Purdue Pharma’s bankruptcy case was heard before the Supreme Court of the United States in December 2023. In June 2024, the Court voted 5-4 against third-party releases contained in the Plan of Reorganization. The decision does nothing to deter us from the twin goals of using settlement dol...
OxyContin creator Purdue Pharma has reached a settlement worth up to $12 billion with thousands of state, tribal, and local governments, lawyers on the case told reporters Wednesday.
The Sackler family will pay up to $6 billion to address damage linked to the US opioid crisis under an amended Purdue Pharma bankruptcy plan following an agreement with holdout states, according to a court filing Thursday. Ad The deal raises the amount that the Sacklers, who own Purdue, mu...
The ruling means that settlement talks must be reset, which ultimately means more time. Purdue Pharma and the billionaire Sacklers have long been viewed as the source of America’s opioid crisis, starting in the 1990s with the debut of prescription painkiller OxyContin. The crisis has since morp...
Stay up-to-date with breaking news and top stories on Purdue Pharma LP. In-depth analysis, industry insights and expert opinion